LANSOPRAZOLE Side Effects

7023651-7 | Condition Aggravated, Gastrooesophageal Reflux Disease, Pain, Product Substitution Issue
on Sep 29, 2010 Female patient from UNITED STATES , weighting 127.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Lansoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, gastrooesophageal reflux disease, pain (What is pain?), product substitution issue. Lansoprazole dosage: 30 Mg 1 Daily In A.m. Po.

7018602-5 | Eosinophilic Fasciitis, Polyneuropathy
Patient was taking Lansoprazole (View Usage). Patient had the following side effects: eosinophilic fasciitis, polyneuropathy on Sep 17, 2010 from FRANCE Additional patient health information: Male patient , 56 years of age, . Lansoprazole dosage: 1 Df (1 Df, 1 In 1 D), Oral. During the same period patient was treated with FLUVASTATIN (Oral) (View Fluvastatin Review and Fluvastatin Label ), ATORVASTATIN CALCIUM (10 Mg (10 Mg, 1 In 1 D), Oral) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), NEXIUM (1 Df (1 Df, 1 In 1 D), Oral) (View Nexium Review and Nexium Label ). Patient was hospitalized.

7017754-0 | Diarrhoea, Hypomagnesaemia
Adverse event was reported on Sep 22, 2010 by a Female patient taking Lansoprazole (View Usage) (Dosage: ) was diagnosed with gastrooesophageal reflux disease and. Location: UNITED KINGDOM , 58 years of age, weighting 187.4 lb, After Lansoprazole was administered, patient had the following side effects: diarrhoea, hypomagnesaemia. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), WARFARIN (View Warfarin Review and Warfarin Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

7016648-4 | Dehydration, Hypoproteinaemia, Toxic Epidermal Necrolysis
on Sep 27, 2010 Female patient from UNITED KINGDOM , 59 years of age, weighting 112.4 lb, was diagnosed with dyspepsia, systemic lupus erythematosus and was treated with Lansoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, hypoproteinaemia, toxic epidermal necrolysis. Lansoprazole dosage: . During the same period patient was treated with HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ). Patient was hospitalized.


7014281-1 | Abdominal Pain, Product Substitution Issue
on Sep 24, 2010 Male patient from UNITED STATES , 68 years of age, weighting 138.0 lb, was diagnosed with peptic ulcer (What is peptic ulcer?) and was treated with Lansoprazole (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), product substitution issue. Lansoprazole dosage: 30mg Daily Oral (6 Mos Trial).

6992662-X | Blood Potassium Decreased, Blood Sodium Decreased, Cardiac Failure, Ileus Paralytic, Inappropriate Antidiuretic Hormone Secretion
Patient was taking Lansoprazole (View Usage). After Lansoprazole was administered, patient had the following side effects: blood potassium decreased, blood sodium decreased, cardiac failure, ileus paralytic, inappropriate antidiuretic hormone secretion on Sep 06, 2010 from ITALY Additional patient health information: Male patient , 80 years of age, was diagnosed with constipation (What is constipation?) and. Lansoprazole dosage: 30 Mg (30 Mg, 1 In 1 D) Oral. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), COUMADIN (View Coumadin Review and Coumadin Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), MICARDIS (View Micardis Review and Micardis Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6991852-X | Abdominal Pain
Adverse event was reported on Sep 16, 2010 by a Male patient taking Lansoprazole (View Usage) (Dosage: 30mg Daily Oral 6 Mos Trial) was diagnosed with peptic ulcer (What is peptic ulcer?) and. Location: UNITED STATES , 68 years of age, weighting 138.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?).

6984881-3 | Cardiac Failure, Faecaloma, Inappropriate Antidiuretic Hormone Secretion
on Aug 30, 2010 Male patient from ITALY , 80 years of age, was diagnosed with constipation (What is constipation?) and was treated with Lansoprazole (View Usage). Patient had the following side effects: cardiac failure, faecaloma, inappropriate antidiuretic hormone secretion. Lansoprazole dosage: 30 Mg (30 Mg, 1 In 1 D). During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), COUMADIN (View Coumadin Review and Coumadin Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), MICARDIS (View Micardis Review and Micardis Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6973907-9 | Colitis Collagenous, Decreased Appetite, Diarrhoea, Hypoproteinaemia, Large Intestinal Ulcer, Oedema Peripheral, Scar
on Aug 31, 2010 Female patient from JAPAN , 81 years of age, was diagnosed with abdominal pain upper and was treated with Lansoprazole (View Usage). After Lansoprazole was administered, patient had the following side effects: colitis collagenous, decreased appetite, diarrhoea, hypoproteinaemia, large intestinal ulcer, oedema peripheral, scar (What is scar?). Lansoprazole dosage: Per Oral. Patient was hospitalized.

6971484-X | Convulsion, Hypomagnesaemia, Lethargy, Muscle Spasms, Nausea
Patient was taking Lansoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, hypomagnesaemia, lethargy, muscle spasms, nausea (What is nausea?) on Aug 25, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 38 years of age, weighting 112.4 lb, was diagnosed with dyspepsia and. Lansoprazole dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CYCLIZINE (View Cyclizine Review and Cyclizine Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ).

6971483-8 | Convulsion, Hypomagnesaemia, Lethargy, Muscle Spasms, Nausea
Adverse event was reported on Aug 25, 2010 by a Female patient taking Lansoprazole (View Usage) (Dosage: ) was diagnosed with dyspepsia and. Location: UNITED KINGDOM , 38 years of age, weighting 112.4 lb, Patient had the following side effects: convulsion, hypomagnesaemia, lethargy, muscle spasms, nausea (What is nausea?). During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CYCLIZINE (View Cyclizine Review and Cyclizine Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ).

6969537-5 | Product Quality Issue
on Sep 07, 2010 Female patient from UNITED STATES , weighting 145.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Lansoprazole (View Usage). After Lansoprazole was administered, patient had the following side effects: product quality issue. Lansoprazole dosage: .

6969119-5 | Hypomagnesaemia
on Aug 25, 2010 Female patient from UNITED KINGDOM , 38 years of age, weighting 112.4 lb, was diagnosed with dyspepsia and was treated with Lansoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: hypomagnesaemia. Lansoprazole dosage: 30 Mg, Unk. During the same period patient was treated with OMEPRAZOLE (NGX) (20 Mg) (View Omeprazole (ngx) Review and Omeprazole (ngx) Label ), CYCLIZINE (50 Mg As Necessary) (View Cyclizine Review and Cyclizine Label ), GABAPENTIN (100 Mg, Tid) (View Gabapentin Review and Gabapentin Label ), MORPHINE SULFATE (10 Mg, Bid) (View Morphine Sulfate Review and Morphine Sulfate Label ).

6964077-1 | Device Dislocation, Febrile Neutropenia, Gastric Ulcer, White Blood Cell Count Decreased, Wound Secretion
Patient was taking Lansoprazole (View Usage). Patient had the following side effects: device dislocation, febrile neutropenia, gastric ulcer, white blood cell count decreased, wound secretion on Aug 16, 2010 from JAPAN Additional patient health information: Male patient , 60 years of age, was diagnosed with duodenal ulcer, inflammation and. Lansoprazole dosage: 15 Mg (15 Mg, 1-2), Per Oral. During the same period patient was treated with NASPALUN (CEFOPERAZONE SODIUM, SULBACTAM SODIUM) (2 Df (1 Df, 2 In 1 D); Intravenous Drip) (View Naspalun (cefoperazone Sodium, Sulbactam Sodium) Review and Naspalun (cefoperazone Sodium, Sulbactam Sodium) Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), HERBAL PREPARATION (View Herbal Preparation Review and Herbal Preparation Label ).

6961603-3 | Cirrhosis Alcoholic, Hepatitis C Virus Test Positive, Rash, Thrombocytopenia
Adverse event was reported on Aug 19, 2010 by a Male patient taking Lansoprazole (View Usage) (Dosage: ) was diagnosed with reflux oesophagitis, schizophrenia, anxiety (What is anxiety?) and. Location: UNITED KINGDOM , 31 years of age, After Lansoprazole was administered, patient had the following side effects: cirrhosis alcoholic, hepatitis c virus test positive, rash (What is rash?), thrombocytopenia. During the same period patient was treated with CLOZARIL (View Clozaril Review and Clozaril Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ).

6956839-1 | Fatigue, Gynaecomastia, Hyperthyroidism
on Aug 11, 2010 Male patient from UNITED KINGDOM , 83 years of age, was diagnosed with hyperthyroidism and was treated with Lansoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, gynaecomastia, hyperthyroidism. Lansoprazole dosage: . During the same period patient was treated with CARBIMAZOLE (View Carbimazole Review and Carbimazole Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6956834-2 | Electrocardiogram Abnormal
on Aug 10, 2010 Male patient from UNITED KINGDOM , 35 years of age, was diagnosed with schizophrenia and was treated with Lansoprazole (View Usage). Patient had the following side effects: electrocardiogram abnormal. Lansoprazole dosage: 60 Mg (30 Mg, 2 In 1 D). During the same period patient was treated with ALCOHOL (ETHANOL) (View Alcohol (ethanol) Review and Alcohol (ethanol) Label ), COCAINE (COCAINE) (View Cocaine (cocaine) Review and Cocaine (cocaine) Label ), DICLOFENAC (150 Mg (50 Mg, 3 In 1 D)) (View Diclofenac Review and Diclofenac Label ), ETHYLAMPHETAMINE (View Ethylamphetamine Review and Ethylamphetamine Label ), METHADONE HCL (80 Mg (80 Mg, 1 In 1 D)) (View Methadone Hcl Review and Methadone Hcl Label ), RISPERDAL CONSTA (50 Mg (50 Mg, 1 In 2 Wk) Intramuscular) (View Risperdal Consta Review and Risperdal Consta Label ), RISPERIDONE (2 Mg (2 Mg, 1 In 1 D) Per Oral) (View Risperidone Review and Risperidone Label ), TETRABENAZINE (12.5 Mg (12.5 Mg, 1 In 1 D)) (View Tetrabenazine Review and Tetrabenazine Label ). Patient was hospitalized.

6946873-X | Autoimmune Hepatitis, Blood Pressure Increased, Condition Aggravated, Erythema Multiforme, Hepatic Failure, Immune System Disorder, Impaired Work Ability, Liver Disorder, Pain Of Skin
Patient was taking Lansoprazole (View Usage). After Lansoprazole was administered, patient had the following side effects: autoimmune hepatitis, blood pressure increased, condition aggravated, erythema multiforme, hepatic failure, immune system disorder, impaired work ability, liver disorder, pain of skin on Aug 04, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 60 years of age, was diagnosed with prophylaxis and. Lansoprazole dosage: . During the same period patient was treated with HAVRIX (1440 Elisa Unit) (View Havrix Review and Havrix Label ), PREDNISOLONE (See Image) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized and became disabled.

6943068-0 | Cirrhosis Alcoholic, Hepatitis C Virus Test Positive, Rash, Thrombocytopenia
Adverse event was reported on Aug 19, 2010 by a Male patient taking Lansoprazole (View Usage) (Dosage: ) was diagnosed with reflux oesophagitis, schizophrenia and. Location: UNITED KINGDOM , 31 years of age, Patient experienced the following unwanted or unexpected effects: cirrhosis alcoholic, hepatitis c virus test positive, rash (What is rash?), thrombocytopenia. During the same period patient was treated with CLOZAPINE (View Clozapine Review and Clozapine Label ).

6942986-7 | Chills
on Aug 17, 2010 Female patient from UNITED KINGDOM , 87 years of age, weighting 167.6 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Lansoprazole (View Usage). Patient had the following side effects: chills. Lansoprazole dosage: . Patient was hospitalized and became disabled.

6941277-8 | Rash
on Aug 19, 2010 Male patient from UNITED KINGDOM , 31 years of age, was diagnosed with reflux oesophagitis, anxiety (What is anxiety?), schizophrenia and was treated with Lansoprazole (View Usage). After Lansoprazole was administered, patient had the following side effects: rash (What is rash?). Lansoprazole dosage: . During the same period patient was treated with OXAZEPAM (View Oxazepam Review and Oxazepam Label ), CLOZARIL (View Clozaril Review and Clozaril Label ).

6939621-0 | Electrocardiogram Abnormal
Patient was taking Lansoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram abnormal on Aug 10, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 35 years of age, was diagnosed with schizophrenia and. Lansoprazole dosage: . During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), ALCOHOL (View Alcohol Review and Alcohol Label ), AMPHETAMINE SULFATE (View Amphetamine Sulfate Review and Amphetamine Sulfate Label ), COCAINE (View Cocaine Review and Cocaine Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), METHADONE (View Methadone Review and Methadone Label ), RISPERDAL CONSTA (View Risperdal Consta Review and Risperdal Consta Label ). Patient was hospitalized.

6939620-9 | Hypomagnesaemia
Adverse event was reported on Aug 10, 2010 by a Male patient taking Lansoprazole (View Usage) (Dosage: 30 Mg/day) was diagnosed with barrett's oesophagus and. Location: ITALY , 65 years of age, Patient had the following side effects: hypomagnesaemia. During the same period patient was treated with PANTOPRAZOLE (40 Mg/day) (View Pantoprazole Review and Pantoprazole Label ), METFORMIN (View Metformin Review and Metformin Label ), CANDESARTAN CILEXETIL (16 Mg/day) (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ). Patient was hospitalized.

6939415-6 | Colitis Collagenous, Constipation, Hypoproteinaemia, Oedema Peripheral
on Aug 09, 2010 Male patient from JAPAN , 88 years of age, was diagnosed with reflux oesophagitis and was treated with Lansoprazole (View Usage). After Lansoprazole was administered, patient had the following side effects: colitis collagenous, constipation (What is constipation?), hypoproteinaemia, oedema peripheral. Lansoprazole dosage: 15 Mg (15 Mg,1 In 1 D) Per Oral ; 30 Mg (30 Mg,1 In 1 D) Per Oral. During the same period patient was treated with GASMOTIN (MOSAPRIDE CITRATE) (View Gasmotin (mosapride Citrate) Review and Gasmotin (mosapride Citrate) Label ), NORVASC (View Norvasc Review and Norvasc Label ), BERIZYM (ENZYMES NOS) (View Berizym (enzymes Nos) Review and Berizym (enzymes Nos) Label ), FOIPAN (CAMOSTAT MESILATE) (View Foipan (camostat Mesilate) Review and Foipan (camostat Mesilate) Label ), PURSENNID (SENNA ALEXANDRINA LEAF) (View Pursennid (senna Alexandrina Leaf) Review and Pursennid (senna Alexandrina Leaf) Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

6937132-X | Hypocalcaemia, Hypomagnesaemia
on Jun 01, 2010 Male patient from UNITED KINGDOM , 67 years of age, weighting 156.5 lb, was diagnosed with barrett's oesophagus and was treated with Lansoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: hypocalcaemia, hypomagnesaemia. Lansoprazole dosage: . During the same period patient was treated with ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ). Patient was hospitalized.

6935675-6 | Autoimmune Thrombocytopenia, Genital Haemorrhage, Haemorrhage Subcutaneous, Idiopathic Thrombocytopenic Purpura, Platelet Count Decreased, Systemic Lupus Erythematosus
Patient was taking Lansoprazole (View Usage). Patient had the following side effects: autoimmune thrombocytopenia, genital haemorrhage, haemorrhage subcutaneous, idiopathic thrombocytopenic purpura, platelet count decreased, systemic lupus erythematosus on Aug 06, 2010 from JAPAN Additional patient health information: Female patient , 56 years of age, was diagnosed with abdominal pain upper, prophylaxis, arthralgia and. Lansoprazole dosage: 15 Mg (15 Mg,1 In 1 D),per Oral. During the same period patient was treated with GABAPENTIN (600 Mg (200 Mg,3 In 1 D) Per Oral) (View Gabapentin Review and Gabapentin Label ), ALPROSTADIL ((1 In 1 Wk) Intravenous Drip) (View Alprostadil Review and Alprostadil Label ), CELECOXIB (400 Mg (200mg,2 In 1 D) Per Oral) (View Celecoxib Review and Celecoxib Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ). Patient was hospitalized.

6933208-1 | Hypomagnesaemia
Adverse event was reported on Aug 09, 2010 by a Male patient taking Lansoprazole (View Usage) (Dosage: ) . Location: ITALY , 65 years of age, After Lansoprazole was administered, patient had the following side effects: hypomagnesaemia. During the same period patient was treated with PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6931223-5 | Fall, Hepatitis Fulminant
on Jul 30, 2010 Male patient from FRANCE , 87 years of age, was diagnosed with depression (What is depression?) and was treated with Lansoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), hepatitis fulminant. Lansoprazole dosage: 15 Mg (15 Mg,1 In 1 D) Oral. During the same period patient was treated with CYMBALTA (60 Mg (60 Mg,1 In 1 D) Oral) (View Cymbalta Review and Cymbalta Label ), ATARAX (25 Mg (25 Mg,1 In 2 D) Oral) (View Atarax Review and Atarax Label ), ANAFRANIL (25 Mg (25 Mg,1 In 1 D) Oral) (View Anafranil Review and Anafranil Label ), LORAZEPAM (1.25 Mg (1.25 Mg, 1 In 1 D) Oral) (View Lorazepam Review and Lorazepam Label ), KARDEGIC (ACETYLSALICYLIC LYSINE) (75 Mg (75 Mg,1 In 1 D) Oral) (View Kardegic (acetylsalicylic Lysine) Review and Kardegic (acetylsalicylic Lysine) Label ), DIAMICRON (GLICLAZIDE) (30 Mg (30 Mg,1 In 1 D) Oral) (View Diamicron (gliclazide) Review and Diamicron (gliclazide) Label ), FUROSEMIDE (40 Mg (40 Mg,1 In 1 D) Oral) (View Furosemide Review and Furosemide Label ), POTASSIUM CHLORIDE (600 Mg (600 Mg,1 In 1 D) Oral) (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6930463-9 | Febrile Neutropenia
on Aug 05, 2010 Male patient from JAPAN , 60 years of age, was treated with Lansoprazole (View Usage). Patient had the following side effects: febrile neutropenia. Lansoprazole dosage: 15 Mg (15 Mg,1 In 1 D) Per Oral. During the same period patient was treated with URSO 250 (View Urso 250 Review and Urso 250 Label ).

6930215-X | Diarrhoea, Pruritus, Rash, Swelling
Patient was taking Lansoprazole (View Usage). After Lansoprazole was administered, patient had the following side effects: diarrhoea, pruritus, rash (What is rash?), swelling on Aug 17, 2010 from UNITED STATES Additional patient health information: Male patient , 73 years of age, weighting 172.0 lb, . Lansoprazole dosage: 30mg 1 Daily Oral. Patient was hospitalized.

6929286-6 | Autoimmune Hepatitis, Blood Pressure Increased, Carbohydrate Antigen 19-9 Increased, Erythema Multiforme, Immune System Disorder, Impaired Work Ability, Infectious Mononucleosis, Peripheral Coldness, Weight Increased
Adverse event was reported on Aug 04, 2010 by a Female patient taking Lansoprazole (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: UNITED KINGDOM , 60 years of age, weighting 196.2 lb, Patient experienced the following unwanted or unexpected effects: autoimmune hepatitis, blood pressure increased, carbohydrate antigen 19-9 increased, erythema multiforme, immune system disorder, impaired work ability, infectious mononucleosis (What is infectious mononucleosis?), peripheral coldness, weight increased. During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), HAVRIX (View Havrix Review and Havrix Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6929285-4 | Autoimmune Hepatitis, Blood Pressure Increased, Carbohydrate Antigen 19-9 Increased, Erythema Multiforme, Immune System Disorder, Impaired Work Ability, Infectious Mononucleosis, Peripheral Coldness, Weight Increased
on Aug 04, 2010 Female patient from UNITED KINGDOM , 60 years of age, weighting 196.2 lb, was diagnosed with prophylaxis and was treated with Lansoprazole (View Usage). Patient had the following side effects: autoimmune hepatitis, blood pressure increased, carbohydrate antigen 19-9 increased, erythema multiforme, immune system disorder, impaired work ability, infectious mononucleosis (What is infectious mononucleosis?), peripheral coldness, weight increased. Lansoprazole dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), HAVRIX (View Havrix Review and Havrix Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6929284-2 | Autoimmune Hepatitis, Blood Pressure Increased, Carbohydrate Antigen 19-9 Increased, Erythema Multiforme, Immune System Disorder, Impaired Work Ability, Infectious Mononucleosis, Peripheral Coldness, Weight Increased
on Aug 04, 2010 Female patient from UNITED KINGDOM , 60 years of age, weighting 196.2 lb, was diagnosed with prophylaxis and was treated with Lansoprazole (View Usage). After Lansoprazole was administered, patient had the following side effects: autoimmune hepatitis, blood pressure increased, carbohydrate antigen 19-9 increased, erythema multiforme, immune system disorder, impaired work ability, infectious mononucleosis (What is infectious mononucleosis?), peripheral coldness, weight increased. Lansoprazole dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), HAVRIX (View Havrix Review and Havrix Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6923803-8 | Areflexia, Ataxia, Balance Disorder, Bundle Branch Block, Confusional State, Decreased Appetite, Delirium, Depressed Level Of Consciousness, Dizziness
Patient was taking Lansoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: areflexia, ataxia (What is ataxia?), balance disorder, bundle branch block, confusional state, decreased appetite, delirium, depressed level of consciousness, dizziness (What is dizziness?) on Aug 04, 2010 from ITALY Additional patient health information: Male patient , 65 years of age, . Lansoprazole dosage: 30 Mg/day. During the same period patient was treated with PANTOPRAZOLE (40 Mg/day) (View Pantoprazole Review and Pantoprazole Label ), METFORMIN HCL (500 Mg, Bid) (View Metformin Hcl Review and Metformin Hcl Label ), CANDESARTAN (16 Mg/day) (View Candesartan Review and Candesartan Label ), RANITIDINE (300 Mg, Qd) (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

6917792-X | Vision Blurred
Adverse event was reported on Jul 14, 2010 by a Male patient taking Lansoprazole (View Usage) (Dosage: 15 Mg (15 Mg, 1 In 1 D) Per Oral) . Location: JAPAN , 75 years of age, Patient had the following side effects: vision blurred. During the same period patient was treated with CALSLOT (MANIDIPINE HYDROCHLORIDE) (View Calslot (manidipine Hydrochloride) Review and Calslot (manidipine Hydrochloride) Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), FLUITRAN (TRICHLORMETHIAZIDE) (View Fluitran (trichlormethiazide) Review and Fluitran (trichlormethiazide) Label ), CEROCRAL (IFENPRODIL TARTRATE) (View Cerocral (ifenprodil Tartrate) Review and Cerocral (ifenprodil Tartrate) Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ).

6915584-9 | Haematemesis, Ileus Paralytic, Oliguria, Pseudomembranous Colitis
on Jul 29, 2010 Female patient from JAPAN , 66 years of age, was treated with Lansoprazole (View Usage). After Lansoprazole was administered, patient had the following side effects: haematemesis, ileus paralytic, oliguria, pseudomembranous colitis. Lansoprazole dosage: . During the same period patient was treated with BETAMIPRON, PANIPENEM (Injection) (View Betamipron, Panipenem Review and Betamipron, Panipenem Label ), LOXOPROFEN SODIUM (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ).

6915061-5 | Convulsion, Hypocalcaemia, Hypoparathyroidism
on Jul 26, 2010 Female patient from UNITED STATES , 48 years of age, was diagnosed with helicobacter infection and was treated with Lansoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, hypocalcaemia, hypoparathyroidism. Lansoprazole dosage: . During the same period patient was treated with CALCIUM CARBONATE (1800mg Of Elemental Calcium) (View Calcium Carbonate Review and Calcium Carbonate Label ), COLECALCIFEROL (View Colecalciferol Review and Colecalciferol Label ). Patient was hospitalized.

6910117-5 | Colitis, Diarrhoea, Weight Decreased
Patient was taking Lansoprazole (View Usage). Patient had the following side effects: colitis, diarrhoea, weight decreased on Jul 30, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 79 years of age, weighting 105.8 lb, . Lansoprazole dosage: . Patient was hospitalized and became disabled.

6907621-2 | Diarrhoea, Hypocalcaemia, Hypomagnesaemia
Adverse event was reported on Jul 26, 2010 by a Male patient taking Lansoprazole (View Usage) (Dosage: ) was diagnosed with barrett's oesophagus and. Location: UNITED KINGDOM , 67 years of age, weighting 156.5 lb, After Lansoprazole was administered, patient had the following side effects: diarrhoea, hypocalcaemia, hypomagnesaemia. During the same period patient was treated with IRBESARTAN (View Irbesartan Review and Irbesartan Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ). Patient was hospitalized.

6896814-9 | Fatigue, Gynaecomastia, Hyperthyroidism
on Jul 13, 2010 Male patient from UNITED KINGDOM , 83 years of age, was treated with Lansoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, gynaecomastia, hyperthyroidism. Lansoprazole dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ).

6882717-2 | Diarrhoea, Hypocalcaemia, Hypomagnesaemia
on Jul 23, 2010 Male patient from UNITED KINGDOM , 67 years of age, weighting 156.5 lb, was diagnosed with barrett's oesophagus and was treated with Lansoprazole (View Usage). Patient had the following side effects: diarrhoea, hypocalcaemia, hypomagnesaemia. Lansoprazole dosage: . Patient was hospitalized.

6878713-1 | Convulsion, Hypocalcaemia, Hypoparathyroidism, Muscle Spasms
Patient was taking Lansoprazole (View Usage). After Lansoprazole was administered, patient had the following side effects: convulsion, hypocalcaemia, hypoparathyroidism, muscle spasms on Jul 19, 2010 from UNITED STATES Additional patient health information: Female patient , 48 years of age, was diagnosed with helicobacter infection and. Lansoprazole dosage: 30 Mg, Bid. During the same period patient was treated with CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), COLECALCIFEROL (View Colecalciferol Review and Colecalciferol Label ).

6876824-8 | Fatigue, Gynaecomastia, Hyperthyroidism
Adverse event was reported on Jul 13, 2010 by a Male patient taking Lansoprazole (View Usage) (Dosage: ) was diagnosed with hyperthyroidism and. Location: UNITED KINGDOM , 83 years of age, Patient experienced the following unwanted or unexpected effects: fatigue, gynaecomastia, hyperthyroidism. During the same period patient was treated with TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), CARBIMAZOLE (View Carbimazole Review and Carbimazole Label ).

6876821-2 | Fatigue, Gynaecomastia, Hyperthyroidism
on Jul 13, 2010 Male patient from UNITED KINGDOM , 83 years of age, was diagnosed with hyperthyroidism and was treated with Lansoprazole (View Usage). Patient had the following side effects: fatigue, gynaecomastia, hyperthyroidism. Lansoprazole dosage: . During the same period patient was treated with TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), CARBIMAZOLE (View Carbimazole Review and Carbimazole Label ).

6876820-0 | Fatigue, Gynaecomastia, Hyperthyroidism
on Jul 13, 2010 Male patient from UNITED KINGDOM , 83 years of age, was diagnosed with hyperthyroidism and was treated with Lansoprazole (View Usage). After Lansoprazole was administered, patient had the following side effects: fatigue, gynaecomastia, hyperthyroidism. Lansoprazole dosage: . During the same period patient was treated with TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), CARBIMAZOLE (View Carbimazole Review and Carbimazole Label ).

6876721-8 | Colitis Collagenous, Venous Thrombosis
Patient was taking Lansoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: colitis collagenous, venous thrombosis on Jul 13, 2010 from JAPAN Additional patient health information: Female patient , 70 years of age, weighting 112.4 lb, was diagnosed with venous thrombosis limb, cellulitis (What is cellulitis?), nephritis and. Lansoprazole dosage: . During the same period patient was treated with RALOXIFENE HCL (View Raloxifene Hcl Review and Raloxifene Hcl Label ), WARFARIN (View Warfarin Review and Warfarin Label ), PIPERACILLIN (View Piperacillin Review and Piperacillin Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6867823-0 | Hypophagia, Nausea
Adverse event was reported on Jul 22, 2010 by a Male patient taking Lansoprazole (View Usage) (Dosage: 30mg A Day Once A Day Po) was diagnosed with gastrooesophageal reflux disease and. Location: UNITED STATES , 29 years of age, weighting 198.0 lb, Patient had the following side effects: hypophagia, nausea (What is nausea?). Patient was hospitalized.

6862491-6 | Cholecystitis, Cholestasis
on Jul 01, 2010 Female patient from UNITED KINGDOM , 75 years of age, was treated with Lansoprazole (View Usage). After Lansoprazole was administered, patient had the following side effects: cholecystitis, cholestasis. Lansoprazole dosage: 60 Mg, Per Oral. Patient was hospitalized.

6862468-0 | Acute Respiratory Failure, Cardiac Failure Acute, Liver Disorder, Pneumonia Aspiration
on Jul 02, 2010 Female patient from JAPAN , 65 years of age, was diagnosed with reflux oesophagitis and was treated with Lansoprazole (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure, cardiac failure acute, liver disorder, pneumonia aspiration. Lansoprazole dosage: 30 Mg (15 Mg, 2 In 1 D) Per Oral. During the same period patient was treated with LASIX (10 Mg (10 Mg,1 In 1 D) Intravenous) (View Lasix Review and Lasix Label ), CEFOTIAM HYDROCHLORIDE (View Cefotiam Hydrochloride Review and Cefotiam Hydrochloride Label ), SOLDACTONE (POTASSIUM CANRENOATE) (View Soldactone (potassium Canrenoate) Review and Soldactone (potassium Canrenoate) Label ), MAGLAX (MAGNESIUM OXIDE) (View Maglax (magnesium Oxide) Review and Maglax (magnesium Oxide) Label ), ZYPREXA ZYDIS (View Zyprexa Zydis Review and Zyprexa Zydis Label ), SILECE (FLUNITRAZEPAM) (View Silece (flunitrazepam) Review and Silece (flunitrazepam) Label ), GLYCYRON (AMINOACETIC ACID, DL METHIONINE, GLYCYRRHIZIC ACID) (View Glycyron (aminoacetic Acid, Dl-methionine, Glycyrrhizic Acid) Review and Glycyron (aminoacetic Acid, Dl-methionine, Glycyrrhizic Acid) Label ). Patient was hospitalized.

6857949-X | Colitis Collagenous, Colitis Ischaemic, Haematochezia, Large Intestinal Ulcer
Patient was taking Lansoprazole (View Usage). Patient had the following side effects: colitis collagenous, colitis ischaemic, haematochezia, large intestinal ulcer on Jul 05, 2010 from JAPAN Additional patient health information: Female patient , 72 years of age, was diagnosed with reflux oesophagitis and. Lansoprazole dosage: 15 Mg (15 Mg, 1 In 1 D) Per Oral. During the same period patient was treated with BLOPRESS TABLETS 4 (CANDESARTAN CILEXETIL) (View Blopress Tablets 4 (candesartan Cilexetil) Review and Blopress Tablets 4 (candesartan Cilexetil) Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HALCION (View Halcion Review and Halcion Label ), KERLONE (View Kerlone Review and Kerlone Label ), MARZULENE S (LEVOGLUTAMIDE, SODIUM GUALENATE) (View Marzulene S (levoglutamide, Sodium Gualenate) Review and Marzulene S (levoglutamide, Sodium Gualenate) Label ). Patient was hospitalized.